DPYD and Hand-foot syndrome: The majority (>85%) of administered 5-FU is degraded by the enzyme dihydropyrimidine dehydrogenase (DPD) in the liver, generating alpha-fluoro-beta-alanine (FBAL), a catabolite associated with off-target toxicities such as hand-foot syndrome.